EYLEA (aflibercept): New Treatment for Wet ARMD Approved!

Eylea Approved for Wet Macular Degeneration


On Friday (11/20), the FDA approved Eylea for the treatment of wet macular degeneration.  Eylea is another anti-VEGF based treatment designed for intraocular injection.

Eylea has several names.  Eylea is also known as VEGF Trap-Eye.  The generic name is aflibercept.

Eylea = VEGF Trap-Eye = aflibercept

VEGF Trap-Eye Works With Fewer Injections

Several pivotal studies suggest Eylea and Lucentis to be equally ef (Read more...)

Full Story →